Answers are grounded in this paper and cite their sources.
In Pseudomonas aeruginosa, the CbrA-CbrB two component system contributes to catabolism of diverse carbon and nitrogen sources, several virulence attributes, and is required for the elevated fitness of clinically relevant strains with loss-of-function mutations in lasR in passaged cultures. Despite its significance, the mechanism of activation of the CbrA kinase remains unknown. Leveraging the observation that LasR- strains had high CbrA-CbrB signaling that led to increased phosphatase activity, we performed a transposon mutant screen in a LasR- clinical isolate for strains that potentially lost high CbrA-CbrB signaling. Through these studies, we demonstrate that CbrA-CbrB activity correlates with intracellular cysteine abundance and activity is repressed by high or low levels of cellular reducing power. We show that CbrA-CbrB activity is elevated in late-stage cultures and also impacted by stationary phase signaling. Additionally, CbrA-CbrB activity is elevated in the ΔlasR mutant in competition with the wild type and this activity is critical for the ΔlasR mutant competitive. Feedback inhibition of CbrA-CbrB activity suggests the two-component system plays a role in regulating the cellular redox state. Our findings establish a mechanism by which CbrA-CbrB can activate across diverse conditions and contribute to lasR mutant fitness.
No takes yet. Share an insight, caveat, or question.
Conaway et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: